Bhanusupriya Somarouthu, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vena Cava Filters | 3 | 2011 | 261 | 0.440 |
Why?
|
Neurofibromatosis 1 | 2 | 2017 | 560 | 0.360 |
Why?
|
Renal Artery | 1 | 2011 | 351 | 0.330 |
Why?
|
Aneurysm | 1 | 2011 | 337 | 0.300 |
Why?
|
Soft Tissue Neoplasms | 1 | 2014 | 1156 | 0.250 |
Why?
|
Venous Thrombosis | 3 | 2011 | 1303 | 0.230 |
Why?
|
Diagnostic Imaging | 1 | 2018 | 3531 | 0.220 |
Why?
|
Thoracic Neoplasms | 2 | 2016 | 266 | 0.220 |
Why?
|
Ovarian Neoplasms | 5 | 2020 | 4877 | 0.210 |
Why?
|
Immunotherapy | 1 | 2018 | 4649 | 0.200 |
Why?
|
Embolization, Therapeutic | 1 | 2011 | 1418 | 0.190 |
Why?
|
Stents | 1 | 2011 | 3179 | 0.160 |
Why?
|
Molecular Targeted Therapy | 2 | 2020 | 2811 | 0.150 |
Why?
|
Neurofibroma, Plexiform | 1 | 2017 | 66 | 0.140 |
Why?
|
Endovascular Procedures | 1 | 2011 | 2181 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 9 | 2023 | 20555 | 0.130 |
Why?
|
Antineoplastic Agents | 4 | 2020 | 13635 | 0.130 |
Why?
|
Anilides | 1 | 2017 | 411 | 0.120 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2018 | 1222 | 0.110 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2017 | 3356 | 0.110 |
Why?
|
Neoplasms | 2 | 2021 | 22158 | 0.100 |
Why?
|
Viscera | 1 | 2011 | 138 | 0.090 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2020 | 9275 | 0.090 |
Why?
|
Imaging, Three-Dimensional | 1 | 2023 | 4063 | 0.090 |
Why?
|
Plethysmography | 1 | 2010 | 175 | 0.090 |
Why?
|
Music Therapy | 1 | 2011 | 110 | 0.080 |
Why?
|
Stroke | 2 | 2011 | 9749 | 0.080 |
Why?
|
Phlebography | 1 | 2010 | 326 | 0.080 |
Why?
|
Peripheral Vascular Diseases | 1 | 2011 | 488 | 0.080 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2019 | 1726 | 0.070 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2010 | 422 | 0.070 |
Why?
|
Neoplasm Metastasis | 2 | 2019 | 4908 | 0.070 |
Why?
|
Radiography, Interventional | 1 | 2014 | 1121 | 0.070 |
Why?
|
Venous Thromboembolism | 2 | 2010 | 1866 | 0.070 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2019 | 2019 | 0.070 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 1640 | 0.070 |
Why?
|
Ultrasonography, Interventional | 1 | 2014 | 1495 | 0.070 |
Why?
|
Pyridines | 1 | 2017 | 2870 | 0.060 |
Why?
|
Cerebral Angiography | 1 | 2011 | 1281 | 0.060 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2010 | 515 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 7999 | 0.060 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2014 | 1313 | 0.060 |
Why?
|
Health Status Indicators | 1 | 2010 | 968 | 0.060 |
Why?
|
Contrast Media | 2 | 2016 | 5310 | 0.060 |
Why?
|
Thromboembolism | 1 | 2011 | 996 | 0.060 |
Why?
|
Radiopharmaceuticals | 1 | 2014 | 2650 | 0.060 |
Why?
|
Cerebrovascular Disorders | 1 | 2010 | 1475 | 0.060 |
Why?
|
Image Enhancement | 1 | 2014 | 2884 | 0.050 |
Why?
|
Humans | 23 | 2023 | 761326 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 3 | 2017 | 36430 | 0.050 |
Why?
|
Aged, 80 and over | 5 | 2014 | 58946 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2019 | 6332 | 0.050 |
Why?
|
Retrospective Studies | 7 | 2017 | 80575 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2019 | 5363 | 0.050 |
Why?
|
Algorithms | 2 | 2014 | 14025 | 0.050 |
Why?
|
Female | 14 | 2020 | 392485 | 0.050 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2011 | 1427 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 5303 | 0.050 |
Why?
|
Adult | 10 | 2017 | 221122 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2021 | 64645 | 0.050 |
Why?
|
Liver Neoplasms | 1 | 2016 | 4321 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6473 | 0.040 |
Why?
|
Radiography | 1 | 2011 | 6966 | 0.040 |
Why?
|
Ultrasonography | 2 | 2010 | 5970 | 0.040 |
Why?
|
Pulmonary Embolism | 2 | 2010 | 2566 | 0.040 |
Why?
|
Middle Aged | 10 | 2017 | 220774 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2014 | 12972 | 0.040 |
Why?
|
Survival Analysis | 1 | 2011 | 10075 | 0.040 |
Why?
|
Aged | 7 | 2016 | 169179 | 0.030 |
Why?
|
Neoplasm Staging | 2 | 2023 | 11098 | 0.030 |
Why?
|
Iohexol | 1 | 2016 | 204 | 0.030 |
Why?
|
Sensitivity and Specificity | 3 | 2016 | 14665 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2019 | 13333 | 0.030 |
Why?
|
Prevalence | 1 | 2010 | 15719 | 0.030 |
Why?
|
Lymph Nodes | 1 | 2023 | 3469 | 0.020 |
Why?
|
Tumor Burden | 1 | 2017 | 1887 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2014 | 20092 | 0.020 |
Why?
|
Ovary | 1 | 2014 | 959 | 0.020 |
Why?
|
Young Adult | 3 | 2011 | 59196 | 0.020 |
Why?
|
Prognosis | 3 | 2016 | 29588 | 0.020 |
Why?
|
Time | 1 | 2010 | 545 | 0.020 |
Why?
|
Male | 5 | 2014 | 360621 | 0.020 |
Why?
|
Pregnancy | 1 | 2010 | 29858 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2015 | 1535 | 0.020 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2011 | 366 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2016 | 15262 | 0.020 |
Why?
|
Disease Progression | 2 | 2017 | 13500 | 0.020 |
Why?
|
United States | 2 | 2019 | 72317 | 0.020 |
Why?
|
Vena Cava, Inferior | 1 | 2010 | 459 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2023 | 8997 | 0.020 |
Why?
|
Conscious Sedation | 1 | 2011 | 532 | 0.020 |
Why?
|
Arteries | 1 | 2011 | 1125 | 0.020 |
Why?
|
Fluoroscopy | 1 | 2010 | 947 | 0.020 |
Why?
|
Risk Factors | 2 | 2010 | 74152 | 0.020 |
Why?
|
Adolescent | 1 | 2014 | 88305 | 0.020 |
Why?
|
Device Removal | 1 | 2010 | 630 | 0.020 |
Why?
|
Observer Variation | 1 | 2011 | 2605 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2011 | 1432 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3687 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10203 | 0.010 |
Why?
|
Software | 1 | 2017 | 4439 | 0.010 |
Why?
|
Genomics | 1 | 2019 | 5817 | 0.010 |
Why?
|
Prosthesis Design | 1 | 2010 | 2115 | 0.010 |
Why?
|
Hypnotics and Sedatives | 1 | 2011 | 1178 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 5665 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 2691 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2014 | 39108 | 0.010 |
Why?
|
Prospective Studies | 2 | 2017 | 54405 | 0.010 |
Why?
|
Heart Rate | 1 | 2011 | 4197 | 0.010 |
Why?
|
Boston | 1 | 2011 | 9333 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2011 | 7045 | 0.010 |
Why?
|
Pilot Projects | 1 | 2011 | 8632 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2011 | 7824 | 0.010 |
Why?
|
Anxiety | 1 | 2011 | 4571 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2011 | 4477 | 0.010 |
Why?
|
Blood Pressure | 1 | 2011 | 8485 | 0.010 |
Why?
|
Anticoagulants | 1 | 2010 | 4813 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 30044 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2011 | 7389 | 0.010 |
Why?
|
Risk Assessment | 1 | 2014 | 23981 | 0.010 |
Why?
|
Time Factors | 1 | 2011 | 39974 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2010 | 15647 | 0.000 |
Why?
|